Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a... von Ongoren, Seniz, Eskazan, Ahmet Emre, Suzan, Veysel, Savci, Sercan, Erdogan Ozunal, Isil, Berk, Selin, Yalniz, Fevzi Fırat, Elverdi, Tugrul, Salihoglu, Ayse, Erbilgin, Yucel, Iseri, Sibel Aylin, Ar, Muhlis Cem, Baslar, Zafer, Aydin, Yildiz, Tuzuner, Nukhet, Ozbek, Ugur, Soysal, Teoman

Volltext